Supreme Court of Texas Blog

No. 20-0809
Click for Official Page

NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC. v. CAPITAL ROYALTY PARTNERS II, L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A", L.P., CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P., AND CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "B" (CAYMAN) L.P.

The Court denied review of the petition on December 18, 2020. File Closed

No Opinions

The Court has not issued any opinions in this case.

 

Court of Appeals

Appellate District:14th Court of Appeals
Outcome Below:Aff/Pt and Rev & Ren/Pt
COA Docket No.:14-18-00740-CV
Opinion Author:Honorable Charles Spain

Trial Court

Trial Court:151st District Court
County:Harris
Trial Judge:Honorable Michael C. Engelhart
Trial Docket:2018-24442

Entries on SCOTX Orders Lists

Docket Entries

Date Event Outcome  
2021-01-27 Notice sent to Court of Appeals
2020-12-18 Petition for Review disposed Denied
2020-11-17 Case forwarded to Court
2020-11-11 Response Waiver filed  
2020-10-13 Court reporter/recorder's record
2020-10-13 Supplement to Clerk's/Reporter's Record
2020-10-13 Clerk's Record
2020-10-12 Petition for Review (Petitioner)  

Parties

Party Counsel Role
Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Capital Royalty Partners II (Cayman) L.P., and Capital Royalty Partners II - Parallel Fund "B" (Cayman) L.P.
Mr. Michael Philip Aigen
Mr. Paul Brian Lackey
Respondent
Navidea Biopharmaceuticals, Inc. and Macrophage Therapeutics, Inc.
Mr. Samuel B. Haren
Mr. D. John Neese
Mr. Andrew K. Meade
Petitioner
 
 
...
...